跳至主要内容
临床试验/NCT03456232
NCT03456232Unknown不适用

High-flux Hemodialysis Versus Hemodiafiltration for End-Stage Renal Disease

Guangdong Provincial People's Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年12月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Clearance of moderate molecule substance

研究概览

简要总结

This study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on small and moderate molecule substances clearance. Meanwhile, this study evaluates the effect of high-flux hemodialysis compared to hemodiafiltration on cardiac function. In this self matching study, participants will receive high-flux hemodialysis compared to hemodiafiltration.

详细描述

Hemodialysis using diffusion, ultrafiltration and convection principle to remove harmful substances in the blood and excessive water, is one of the most commonly replacement therapy.

Hemodiafiltration is a combination of hemodialysis and hemofiltration with two modes of treatment advantages, both by diffusion and convection principle to remove harmful substances in the blood.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject has end-stage renal disease.
  • Subject has been on regular dialysis treatment for at least 6 months.
  • Subject has autologous vascular access.
  • Subject is offered thrice weekly hemodialysis.
  • Subject is offered 4 hours duration hemodialysis.

排除标准

  • Infectious disease
  • Poor echocardiographic window that was unsuitable for interpretation

研究组 & 干预措施

High-flux hemodialysis

Experimental

High-flux hemodialysis lasting for 4 hours

干预措施: High-flux hemodialysis (Other)

Hemodiafiltration

Active Comparator

Hemodiafiltration lasting for 4 hours

干预措施: Hemodiafiltration (Other)

结局指标

主要结局

Clearance of moderate molecule substance

时间窗: 4 hours after dialysis

Clearance rate of b2-microglobulin for one dialysis.

次要结局

  • Left ventricular ejection fraction(4 hours after dialysis)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验